InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the detailed record of transactions filed by Rosa David A, Chief Executive Officer. Officer active across 2 companies, notably Biotricity INC.. Cumulatively, 8 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €126k. Activity tracked since 15 September 2021. The latest transaction was filed on 3 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
250,000 shares0Common StockSEC:0001540354-22-000001:0
250,000 shares0Common StockSEC:0001540354-22-000001
27,174 shares0Common StockSEC:0001493152-21-030377:0
27,174 shares0Common StockSEC:0001493152-21-030377
17,228 shares@ US$3.083372.7% of flowCommon StockSEC:0001493152-21-025255
17,228 shares@ US$3.08330.85% mcap36.3% of flowCommon StockSEC:0001493152-21-025255:0
6,246 shares@ US$3.269527.3% of flowCommon StockSEC:0001493152-21-024126
6,246 shares@ US$3.26950.32% mcap13.7% of flowCommon StockSEC:0001493152-21-024126:0
8 of 8 declarations
About Rosa David A
David A. Rosa is a Director, CEO, and President of Biotricity Inc. and Neuroone Medical Technologies Corp. He leads the operations and strategy of both companies, focusing on innovation in the healthcare sector. Rosa plays a key role in product development and market expansion while ensuring that financial objectives are met.
